Sean Bickerton

ORCID: 0000-0002-3514-0308
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • T-cell and B-cell Immunology
  • Immune Cell Function and Interaction
  • Nanoparticle-Based Drug Delivery
  • COVID-19 Clinical Research Studies
  • RNA Interference and Gene Delivery
  • SARS-CoV-2 and COVID-19 Research
  • Immunotherapy and Immune Responses
  • Long-Term Effects of COVID-19
  • Systemic Lupus Erythematosus Research
  • COVID-19 diagnosis using AI
  • Advanced Polymer Synthesis and Characterization
  • Pancreatic function and diabetes
  • Reproductive System and Pregnancy
  • Advanced Drug Delivery Systems
  • CAR-T cell therapy research
  • Anesthesia and Neurotoxicity Research
  • Hydrogels: synthesis, properties, applications
  • COVID-19 and Mental Health
  • Surfactants and Colloidal Systems
  • Dendrimers and Hyperbranched Polymers
  • Supramolecular Chemistry and Complexes
  • Cell Image Analysis Techniques
  • Psoriasis: Treatment and Pathogenesis
  • Biosensors and Analytical Detection
  • COVID-19 Impact on Reproduction

Yale University
2015-2024

University of Massachusetts Amherst
2010-2012

Carolina Lucas Patrick Wong Jon Klein Tiago B. R. Castro Julio Silva and 95 more Maria E. Sundaram Mallory K. Ellingson Tianyang Mao Ji Eun Oh Benjamin Israelow Takehiro Takahashi Maria Tokuyama Peiwen Lu Arvind Venkataraman Annsea Park Subhasis Mohanty Haowei Wang Anne L. Wyllie Chantal B. F. Vogels Rebecca Earnest Sarah Lapidus Isabel M. Ott Adam J. Moore M. Catherine Muenker John Fournier Melissa Campbell Camila D. Odio Arnau Casanovas‐Massana Abeer Obaid Alice Lu-Culligan Allison Nelson Anderson F. Brito Ángela Núñez Anjelica Martin Annie Watkins Bertie Geng Chaney C. Kalinich Christina A. Harden Codruta Todeasa Cole Jensen Daniel Kim David McDonald Denise Shepard Edward Courchaine Elizabeth B. White Eric Song Erin Silva Eriko Kudo Giuseppe DeIuliis Harold Rahming Hong‐Jai Park Irene Matos Jessica Nouws Jordan Valdez Joseph R. Fauver Joseph K. Lim Kadi-Ann Rose Kelly Anastasio Kristina Brower Laura Glick Lokesh Sharma Lorenzo R. Sewanan Lynda Knaggs Maksym Minasyan Maria Batsu Mary E. Petrone Maxine Kuang Maura Nakahata Melissa Campbell Melissa Linehan Michael H. Askenase Michael Simonov Mikhail Smolgovsky Nicole Sonnert Nida Naushad Pavithra Vijayakumar Rick Martinello Rupak Datta Ryan Handoko Santos Bermejo Sarah Prophet Sean Bickerton Sofia Velazquez Tara Alpert Tyler Rice William Khoury-Hanold Xiaohua Peng Yexin Yang Yiyun Cao Yvette Strong Roy S. Herbst Albert C. Shaw Ruslan Medzhitov Wade L. Schulz Nathan D. Grubaugh Charles S. Dela Cruz Shelli Farhadian Albert I. Ko Saad B. Omer Akiko Iwasaki

10.1038/s41586-020-2588-y article EN other-oa Nature 2020-07-27

There is increasing evidence that coronavirus disease 2019 (COVID-19) produces more severe symptoms and higher mortality among men than women1–5. However, whether immune responses against acute respiratory syndrome (SARS-CoV-2) differ between sexes, such differences correlate with the sex difference in course of COVID-19, currently unknown. Here we examined viral loads, SARS-CoV-2-specific antibody titres, plasma cytokines blood-cell phenotyping patients moderate COVID-19 who had not...

10.1038/s41586-020-2700-3 article EN other-oa Nature 2020-08-26

10.1038/s41586-021-03631-y article EN other-oa Nature 2021-05-19

Nanoscopic vehicles that stably encapsulate drug molecules and release them in response to a specific trigger are of great interest due implications therapeutic applications, especially for cancer therapy. For this purpose, we have synthesized highly stable polymeric nanogels, which the kinetics guest molecule can be fine-tuned by control over cross-linking density. The polymer nanogel precursor is based on random copolymer contains oligoethyleneglycol (OEG) pyridyldisulfide (PDS) units as...

10.1021/ja1069932 article EN Journal of the American Chemical Society 2010-11-15

10.1016/j.medj.2020.12.010 article EN publisher-specific-oa Med 2020-12-26
Carolina Lucas Jon Klein Maria E. Sundaram Feimei Liu Patrick Wong and 95 more Julio Silva Tianyang Mao Ji Eun Oh Subhasis Mohanty Jiefang Huang Maria Tokuyama Peiwen Lu Arvind Venkataraman Annsea Park Benjamin Israelow Chantal B. F. Vogels M. Catherine Muenker C‐Hong Chang Arnau Casanovas‐Massana Adam J. Moore Joseph Zell John Fournier Abeer Obaid Alexander J. Robertson Alice Lu-Culligan Alice Zhao Allison Nelson Anderson F. Brito Ángela Núñez Anjelica Martin Anne E. Watkins Bertie Geng Caitlin J. Chun Chaney C. Kalinich Christina A. Harden Codruta Todeasa Cole Jensen Coriann E. Dorgay Daniel Kim David McDonald Denise Shepard Edward Courchaine Elizabeth B. White Eric Song Erin Silva Eriko Kudo Giuseppe DeIuliis Harold Rahming Hong‐Jai Park Irene Matos Isabel M. Ott Jessica Nouws Jordan Valdez Joseph R. Fauver Joseph K. Lim Kadi-Ann Rose Kelly Anastasio Kristina Brower Laura Glick Lokesh Sharma Lorenzo R. Sewanan Lynda Knaggs Maksym Minasyan Maria Batsu Mary E. Petrone Maxine Kuang Maura Nakahata Melissa Linehan Michael H. Askenase Michael Simonov Mikhail Smolgovsky Natasha C. Balkcom Nicole Sonnert Nida Naushad Pavithra Vijayakumar Rick Martinello Rupak Datta Ryan Handoko Santos Bermejo Sarah Prophet Sean Bickerton Sofia Velazquez Tara Alpert Tyler Rice William Khoury-Hanold Xiaohua Peng Yexin Yang Yiyun Cao Yvette Strong Zitong Lin Anne L. Wyllie Melissa Campbell Alfred Ian Lee Hyung J. Chun Nathan D. Grubaugh Wade L. Schulz Shelli Farhadian Charles S. Dela Cruz Aaron M. Ring Albert C. Shaw

10.1038/s41591-021-01355-0 article EN other-oa Nature Medicine 2021-05-05

Abstract Although microbial populations in the gut microbiome are associated with COVID-19 severity, a causal impact on patient health has not been established. Here we provide evidence that dysbiosis is translocation of bacteria into blood during COVID-19, causing life-threatening secondary infections. We first demonstrate SARS-CoV-2 infection induces mice, which correlated alterations to Paneth cells and goblet cells, markers barrier permeability. Samples collected from 96 patients at two...

10.1038/s41467-022-33395-6 article EN cc-by Nature Communications 2022-11-01

The stability of encapsulation in self-assembly systems is limited during blood circulation because a requisite concentration for assembly formation. For deliberate molecular design stable encapsulation, targeting, and triggered release, we have developed facile synthetic method highly stable, polymeric nanogels using simple intra/interchain cross-linking reaction. We show simple, emulsion-free the preparation biocompatible that provides ability to encapsulate hydrophobic guest molecules...

10.1021/ja102316a article EN Journal of the American Chemical Society 2010-05-26

Exchange dynamics of lipophilic guest molecules, encapsulated in supramolecular nanoassemblies aqueous solutions, have implications evaluating the stability drug delivery vehicles. This is because exchange related to propensity a nanocarrier be leaky. We describe fluorescence resonance energy transfer (FRET) based method evaluate phase. utilized this analyze encapsulation polymeric nanogels and other amphiphilic nanoassemblies.

10.1021/ja105059g article EN Journal of the American Chemical Society 2010-07-20

Podocyte malfunction occurs in autoimmune and nonautoimmune kidney disease. Calcium signaling is essential for podocyte injury, but the role of Ca2+/calmodulin-dependent kinase (CaMK) podocytes has not been fully explored. We report that from patients with lupus nephritis focal segmental glomerulosclerosis lupus-prone lipopolysaccharide- or adriamycin-treated mice display increased expression CaMK IV (CaMK4), CaMK2. Mechanistically, CaMK4 modulated motility by altering GTPases Rac1 RhoA...

10.1172/jci99507 article EN Journal of Clinical Investigation 2018-07-08
Manik Kuchroo Jessie Huang Patrick Wong Jean‐Christophe Grenier Dennis Shung and 95 more Alexander Tong Carolina Lucas Jon Klein Daniel B. Burkhardt Scott Gigante Abhinav Godavarthi Bastian Rieck Benjamin Israelow Michael Simonov Tianyang Mao Ji Eun Oh Julio Silva Takehiro Takahashi Camila D. Odio Arnau Casanovas‐Massana John Fournier Abeer Obaid Adam J. Moore Alice Lu-Culligan Allison Nelson Anderson F. Brito Ángela Núñez Anjelica Martin Anne L. Wyllie Annie Watkins Annsea Park Arvind Venkataraman Bertie Geng Chaney C. Kalinich Chantal B. F. Vogels Christina A. Harden Codruta Todeasa Cole Jensen Daniel Kim David McDonald Denise Shepard Edward Courchaine Elizabeth B. White Eric Song Erin Silva Eriko Kudo Giuseppe DeIuliis Haowei Wang Harold Rahming Hong‐Jai Park Irene Matos Isabel M. Ott Jessica Nouws Jordan Valdez Joseph R. Fauver Joseph Lim Kadi-Ann Rose Kelly Anastasio Kristina Brower Laura Glick Lokesh Kumar Sharma Lorenzo R. Sewanan Lynda Knaggs Maksym Minasyan Maria Batsu Maria Tokuyama M. Cate Muenker Mary E. Petrone Maxine Kuang Maura Nakahata Melissa Campbell Melissa Linehan Michael H. Askenase Michael Simonov Mikhail Smolgovsky Nathan D. Grubaugh Nicole Sonnert Nida Naushad Pavithra Vijayakumar Peiwen Lu Rebecca Earnest Rick Martinello Roy S. Herbst Rupak Datta Ryan Handoko Santos Bermejo Sarah Lapidus Sarah Prophet Sean Bickerton Sofia Velazquez Subhasis Mohanty Tara Alpert Tyler Rice Wade L. Schulz William Khoury-Hanold Xiaohua Peng Yexin Yang Yiyun Cao Yvette Strong Shelli Farhadian

10.1038/s41587-021-01186-x article EN Nature Biotechnology 2022-02-28

Nanoscale vehicles for delivery have been of interest and extensively studied two decades. However, the encapsulation stability hydrophobic drug molecules in selective targeting these into disease cells are potential hurdles efficient systems. Here we demonstrate a simple fast synthetic protocol nanogels that shows high stabilities. These can also be modified with various ligands active targeting. We show (T-NGs), which prepared within 2 h by one-pot synthesis, exhibit very narrow size...

10.1021/bm300201x article EN Biomacromolecules 2012-03-29

Abstract Treatment of autoimmune diseases is still largely based on the use systemically acting immunosuppressive drugs, which invariably cause severe side effects. Calcium/calmodulin-dependent protein kinase IV involved in suppression IL-2 and production IL-17. Its pharmacologic or genetic inhibition limits disease mice. In this study, we demonstrate that KN93, a small-molecule inhibitor calcium/calmodulin-dependent IV, targeted to CD4+ T cells via nanolipogel delivery system, markedly...

10.4049/jimmunol.1501603 article EN The Journal of Immunology 2015-11-12

Objective To develop a nanoparticle ( NP ) platform that can expand both CD 4+ and 8+ Treg cells in vivo for the suppression of autoimmune responses systemic lupus erythematosus SLE ). Methods Poly(lactic‐co‐glycolic acid) PLGA s encapsulating interleukin‐2 IL ‐2) transforming growth factor β TGF β) were coated with anti‐ 2/ 4 antibodies administered to mice lupus‐like disease induced by transfer DBA /2 T into (C57 BL /6 × /2)F 1 BDF 1) mice. The peripheral frequency was monitored ex flow...

10.1002/art.40773 article EN Arthritis & Rheumatology 2018-11-08

Defective DNA methylation in T cells leads to a series of cell abnormalities lupus; however, the full effect lineage–specific on disease expression has not been explored. Here, we show that 5-azacytidine, methyltransferase inhibitor, targeted either CD4 or CD8 mice with established using nanolipogel delivery system dramatically ameliorates lupus-related pathology through distinct mechanisms. In vivo 5-azacytidine into favors expansion and function Foxp3+ Tregs, whereas enhances cytotoxicity...

10.1172/jci.insight.120880 article EN JCI Insight 2018-08-22

A 22-month-old male infant presented with cyanosis and stridor after a trivial fall then developed acute respiratory distress. The status of the patient progressed rapidly to severe distress syndrome. Additional findings hypersplenism prompted comprehensive multidisciplinary approach consideration an inborn error metabolism. Rapid whole-genome sequence showed compound heterozygote mutation in GBA1 gene involving maternally inherited known pathogenic variant, p.L484P, paternally novel likely...

10.3389/fped.2025.1476541 article EN cc-by Frontiers in Pediatrics 2025-03-14

Significance Chilblain diagnoses have increased during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and been attributed to viral infection a subsequent robust antiviral immune response. As result, providers managed these cases differently than idiopathic chilblains, which are associated with cold exposure. The relationship between chilblains SARS-CoV-2 infection, however, remains unclear as most patients do not test positive for SARS-CoV-2–specific PCR or...

10.1073/pnas.2122090119 article EN cc-by Proceedings of the National Academy of Sciences 2022-02-25

Polymer-based nanoassemblies have emerged as viable platforms for the encapsulation and delivery of lipophilic molecules. Among criteria that such carriers must meet, if they are to be effective, abilities efficiently solubilize guests within an assembled scaffold stably encapsulate molecular cargo until desired release is achieved through actions appropriately chosen stimuli. The former feature, dictated by inherent loading capacity a nanocarrier, well studied, it has been established...

10.1021/mp3004226 article EN Molecular Pharmaceutics 2012-10-22

Artificial antigen-presenting cells (aAPCs) are synthetic versions of naturally occurring (APCs) that, similar to natural APCs, promote efficient T effector cell responses in vitro . This report describes a method produce acellular tolerogenic aAPCs made biodegradable poly lactic-co-glycolic acid (PLGA) nanoparticles (NPs) and encapsulating IL-2 TGF-β for paracrine release cells. We document that these can induce both human CD4 + CD8 become FoxP3 regulatory (Tregs). The aAPC NP-expanded...

10.3389/fimmu.2021.628059 article EN cc-by Frontiers in Immunology 2021-05-26

We have previously reported that nanoparticles (NPs) loaded with IL-2 and TGF-β targeted to T cells induced polyclonal regulatory (Tregs) protected mice from graft-versus-host disease (GvHD). Here, we evaluated whether administration of these NPs during alloantigen immunization could prevent allograft rejection by converting immunogenic responses tolerogenic ones. Using C57BL/6 BALB/c as either donors or recipients allogeneic splenocytes, found treatment the in both strains resulted a marked...

10.3389/fimmu.2024.1429335 article EN cc-by Frontiers in Immunology 2024-07-26

Abstract Over the last century, outbreaks and pandemics have occurred with disturbing regularity, necessitating advance preparation large-scale, coordinated response. Here, we developed a machine learning predictive model of disease severity length hospitalization for COVID-19, which can be utilized as platform future unknown viral outbreaks. We combined untargeted metabolomics on plasma data obtained from COVID-19 patients (n = 111) during healthy controls 342), clinical comorbidity 508) to...

10.1186/s40246-023-00521-4 article EN cc-by Human Genomics 2023-08-29

Multiple sclerosis (MS) is a demyelinating autoimmune disease that attacks the brain, with year-on-year loss of brain volume, starting late teens and becoming manifest twenties. There no cure, current therapies are immunosuppressive only. LIF vital stem cell growth factor active throughout life-and essential for health central nervous system (CNS), being tolerogenic, myelinogenic, neuroprotective. Nano-formulation (LIFNano) using FDA-approved PLGA captures LIF's compound therapeutic...

10.3389/fmedt.2021.640569 article EN cc-by Frontiers in Medical Technology 2021-04-07
Coming Soon ...